oncology News
-
Stelvio Oncology Presenting at Indie Bio`s Demo Day on September 14, 2017
I'm very excited to be presenting Stelvio Oncology at Indie Bio's Demo Day on September 14, 2017. I'll be on stage presenting with eleven other great biotechnology startup ...
-
Neotherma Oncology Chooses Master Control as their Quality Management System - Wichita, Kansas
NeoTherma Oncology (NTO) announces they have chosen the Master Control QMS, supporting their strong commitment to quality in all products and services. Master Control is used by over 1000 highly regulated companies and is considered one of the world's leading QMS solutions. ...
-
Stelvio Oncology was successfully accepted into Indie Bio Accelerator
We are proud to announce that Stelvio Oncology was successfully accepted into Indie Bio Accelerator, the world's largest seed biotech ...
-
Stelvio Oncology featured in Popping the Bubbl
Great conversation with Pete Turner and Sandra Ponce de Leon bringing to light how we are discovering novel cancer therapeutics with our innovative ...
-
Growing traction and growing team for Redbiotec’s oncology program
Redbiotec recently hired three additional scientists supporting Redbiotec’s fast growing oncology program. We are happy to observe a big and growing interest in Redbiotec’s COMOS and in Redbiotec’s engineered bacteria. As a consequence Redbiotec will invest further resources in these promising immuno-oncology platforms. Redbiotec is currently also evaluating additional people ...
By Redbiotec AG
-
ESMO 2018 Munich, Germany
This year, we are going to present TMS for the first time in Europe. Visit our booth #117 at ESMO (European Society for Medical Oncology) 2018 in Munich Germany, in October ...
-
Showcase
succeSRS Dosimetry Audit Service
RTsafe launches the Dosimetry Audit Service – succeSRS The complex nature of the stereotactic treatment process demands commitment to the highest levels of accuracy and precision. That being the case we are thrilled to announce the launch of our new dosimetry audit service aiming to promote a culture of excellence. succeSRS is a powerful tool for quality improvement in intracranial ...
By RTsafe
-
2019 Conference Highlights
In 2019, medPhoton attended the North American Spine Society (NASS) and American Society for Radiation Oncology (ASTRO) conferences in Chicago, USA. At ASTRO, the world’s most important event for radiation oncology, medPhoton once again demonstrated products, image guidance solutions for use cases in particle therapy. Shortly afterwards, Brainlab hosted an exclusive by invitation-only ...
-
Aurobindo Pharma’s subsidiary Acrotech Biopharma to acquire portfolio of seven marketed oncology injectable products from Spectrum Pharmaceuticals
Hyderabad, India, 17th January 2019: Aurobindo Pharma Limited (BSE: 524804 and NSE: AUROPHARMA) ("Aurobindo"), announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also brings-in an experienced branded commercial infrastructure in the US. Acrotech Biopharma LLC ...
-
12-13 May: Defymed at the Meet2Win convention
Our president Séverine SIGRIST will be present at the 7th edition of the Meet2Win Convention organised by MATWIN, a national programme dedicated to the acceleration of innovative projects in oncology, from 12 to 13 May 2022 in Bordeaux (France). This convention is a chance to learn about oncology and discover the latest innovations, projects and technologies in the field. This year’s ...
By Defymed
-
NeoTherma Oncology Grows Engineering Leadership Team - WICHITA, Kansas
NeoTherma Oncology (NTO) announces they have expanded their leadership team with key senior staff who will advance the development and commercialization of the VectRx System. NTO’s new additions include: Ken Belt, Chief Engineer: Ken will lead RF design, and has 48 years of experience in the medical device field with extensive experience in MRI coil and phased array engineering. ...
-
Biopticon Reaches Milestone in Market Adoption
Biopticon Corporation reaches milestone in market adoption of their innovative Tumor Management System for preclinical oncology studies. Innovative instrument and software create revolutionary system to improve data, work-flow and results from in vivo cancer models Princeton, NJ Biopticon today announced that it had met its first milestone for customer adoption of the revolutionary ...
-
NeoTherma Oncology Opens Clinical Study - Wichita, Kansas
NeoTherma Oncology, having achieved both FDA approval for its Investigational Device Exemption for an Early Feasibility Study of the VectRx™ System and institutional review board approval at an east coast National Cancer Institute-designated Cancer Center, has initiated recruitment for a first-in-human trial in patients with pancreatic ...
-
NeoTherma Oncology Announces Bob Larson as New Chief Executive Officer - Wichita, Kansas
Neotherma Oncology (NTO) announces the appointment of Bob Larson as Chief Executive Officer effective immediately. Bob is an experienced health care executive with 30+ years spread across the medical device, bio-pharmaceutical, and tech industries. He has held senior leadership positions at companies ranging from startups to Fortune 500 multi-nationals such as Johnson & Johnson and ...
-
AVEO Oncology Announces Participation at the H.C. Wainwright Virtual BioConnect 2022 Conference
AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that members of its senior management team will participate in the H.C. Wainwright Virtual BioConnect 2022 Conference, which is taking place from Monday, January 10th to Thursday, January 13th. A webcast of the fireside chat with AVEO’s management team and H.C. Wainwright research ...
-
Healthcare Technology Leader Laure Tessier-Delivuk Joins Inspirata as Vice President of Operations for Oncology Informatics
Oncology informatics company, Inspirata, is pleased to announce the recent addition of a new key member to the company’s leadership team. Effective November 17, 2022, Laure Tessier-Delivuk, PMP, has joined as Vice President of Operations – Oncology Informatics. Laure brings 25+ years of experience as a Healthcare Technology executive leader and a proven track record in managing ...
-
Filtricine appoints a new Chief Executive Officer
It is our great pleasure to announce that Dr. John Chant has accepted our offer as Chief Executive Officer. John will assume the position on Dec 20, 2020. The Board and the founder team are unanimously supportive and excited to have an industry guru with established track record to take the helm. As Filtricine’s current Strategic Advisor, John has been deeply involved in ...
-
Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the Company plans to participate virtually at the upcoming H.C. Wainwright Global Investment Conference, May 23 ...
-
Cellphire Therapeutics Appoints Roy A. Beveridge, M.D. to Scientific Advisory Board
Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today the appointment of Roy A. Beveridge, M.D. to the company’s Scientific Advisory Board. “Roy is a great addition to our Scientific Advisory Board,” said Mike Gaffney, Chief Executive Officer. ...
-
Tethis’ Reconfirmed Scientific Advisory Board appoints Prof. Nicola Aceto, Ph.D as Chairman
Tethis S.p.A announced today that in the first meeting of the reconfirmed Scientific Advisory Board held today, Nicola Aceto PhD, Professor of Molecular Oncology at the Swiss Federal Institute of Technology (ETH) Zurich, has been appointed as its new chairman. Prof. Aceto is a world-renowned leader in circulating tumor cell research, and his work on CTC clusters has been published in the highest ...
By Tethis S.p.A
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you